Tag: clinical trials
-
Could COVID mRNA Vaccines Help Fight Cancer? New US Study Sparks Hope—and Caution
Can COVID mRNA vaccines boost cancer treatment? Recent research from the United States has sparked interest in a surprising possible benefit of the COVID-19 mRNA vaccine: enhancing the effectiveness of cancer immunotherapy. In a retrospective analysis of more than 1,000 patient records, researchers found that patients with advanced lung cancer or metastatic skin cancer (melanoma)…
-
Global Lobular Breast Cancer Awareness Day Highlights Need for Improved Detection and Treatment
Raising Awareness for a Less-Recognized Breast Cancer Subtype Last week, lobular breast cancer patients and their providers gathered at Fred Hutch Cancer Center for a two-hour program timed to Global Lobular Breast Cancer Awareness Day. The event highlighted patient stories, epidemiological findings, and the latest developments in screening and clinical trials for invasive lobular carcinoma…
-
Advancing Awareness and Innovation in Invasive Lobular Breast Cancer: Lessons from a Fred Hutch Event
Global Lobular Breast Cancer Day shines spotlight on ILC challenges and breakthroughs Last week, invasive lobular breast cancer (ILC) patients and their care teams gathered at Fred Hutch Cancer Center for a focused two-hour program. The event, held on October 15 to mark Global Lobular Breast Cancer Awareness Day, brought patient stories, epidemiological insights, and…
-
Patient Stories and New Research Highlight Invasive Lobular Breast Cancer Awareness Event at Fred Hutch
Overview of the Event and Its Purpose Last week, invasive lobular breast cancer (ILC) patients and healthcare providers gathered at Fred Hutch Cancer Center for a two-hour program dedicated to Global Lobular Breast Cancer Awareness Day. The event highlighted patient stories, epidemiological findings, and cutting-edge developments in screening and clinical trials for this common breast…
-
Ozempic sober: Could GLP-1 meds dull alcohol intoxication and aid AUD treatment?
What is the new finding about GLP-1 medications and alcohol? Recent early research has sparked interest in whether GLP-1 receptor agonists — including popular drugs like Ozempic (semaglutide) — can change how the body handles alcohol. In a pilot study with adults who are overweight or obese, researchers observed a slower rise in blood alcohol…
-
Changing the Narrative: How Calgary’s iSARP Is Redefining Sarcoma Therapy
Changing the Narrative in Calgary’s Medical Landscape When Dr. Michael Monument returned to his hometown of Calgary in 2014 after a fellowship at the University of Utah, colleagues warned him that the city might not be the best place to pursue sarcoma research. Sarcoma, a relatively rare family of bone and soft tissue tumors that…
-
Canada’s Cancer Research Leap: LHSF Verspeeten Endowed Chairs Accelerate Translational and Oncological Discoveries
A Bold Canadian Commitment to Cancer Research Canada stands at a pivotal moment in the fight against cancer as a landmark philanthropic effort accelerates research from the lab bench to the patient’s bedside. An extraordinary $5 million donation from the late Archie and Irene Verspeeten, channeled through the London Health Sciences Foundation (LHSF) and matched…
-
Landmark ADA-SCID Gene Therapy Delivers Life-Changing Results for Portlaoise Boy
Life-changing outcomes from a landmark ADA-SCID gene therapy trial A nine-year-old boy from Portlaoise, Ireland, has experienced life-changing results after taking part in a landmark medical trial targeting ADA-SCID, a rare and life-threatening immune disorder. The trial, conducted at Great Ormond Street Hospital (GOSH) in London as part of an international collaboration, marks a major…
-
Experts Call for Action Against Imposter Participants in Health Studies
What are imposter participants? Imposter participants are individuals who provide deceptive or inaccurate data to participate in health research, or automated computer bots that mimic human responses. As online recruitment becomes central to modern health studies—from surveys to randomized trials—the potential for these imposters to skew results grows. The concern, highlighted by Eileen Morrow and…
-
Is this response real? Imposters threaten health studies
What is at stake when imposters join health studies? Recent concerns from researchers highlight a troubling trend: impostor participants slipping into quantitative health studies. The integrity of data collected in surveys and trials can be compromised when individuals misrepresent themselves or automate their responses for ulterior motives. When the underlying data are unreliable, the clinical…